Consequently, the DNA methylation biomarkers RASSF1A, MIR129-2, NRIP3, and SOX8 were combined with the amount of cfDNA/mL and patient’s age to develop two PSA-independent PCa risk scores. The gene discussed is SOX8; the disease is posterior cortical atrophy.